Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension-Reference-Cited by-同舟云学术

Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension

Published:2014-04 Issue:4 Volume:63 Page:698-705
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Kario Kazuomi¹,Sun Ningling¹,Chiang Fu-Tien¹,Supasyndh Ouppatham¹,Baek Sang Hong¹,Inubushi-Molessa Akiko¹,Zhang Ying¹,Gotou Hiromi¹,Lefkowitz Martin¹,Zhang Jack¹

Affiliation:

1. From the Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Peking University People’s Hospital, Beijing, China (N.S.); National Taiwan University Hospital, Taipei, Taiwan (F.-T.C.); Phramongkutklao Hospital, Bangkok, Thailand (O.S.); Seoul St Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea (S.H.B.); Novartis Pharmaceuticals Corporation, East Hanover, NJ (A.I.-M., Y.Z., M.L., J.Z.); and Novartis...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference35 articles.

1. Blood pressure and cardiovascular disease in the Asia Pacific region

2. Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels

3. Cardiovascular Disease and Risk Factors in Asia

4. Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP

5. Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Resistant Hypertension;Annual Review of Medicine;2024-01-29

2. Research Progress of Sacubitril/Valsartan in the Treatment of Patients with Resistant Hypertension;Advances in Clinical Medicine;2024

3. Renin Angiotensin Aldosterone System Blockers;Hypertension;2024

4. Sacubitril/Valsartan in Heart Failure with Hypertension Patients: Real-World Experiences on Different Ages, Drug Doses, and Renal Functions;High Blood Pressure & Cardiovascular Prevention;2023-11-18

5. Evaluation of the Efficacy of Sacubitril/Valsartan on Radiofrequency Ablation in Patients with Hypertension and Persistent Atrial Fibrillation;Cardiovascular Drugs and Therapy;2023-09-07